Funding opportunity available to UK and Chinese researchers to help tackle antimicrobial resistance (AMR)

The Department of Health and Social Care (DHSC) will invest up to £10 million in UK businesses and academics who work in conjunction with Chinese scientists to advance work on antimicrobial resistance (AMR). The fund is to support the development and, where appropriate, clinical evaluation of new products or services, which must be of value in addressing the threat from AMR.

Innovate UK will deliver the funding to UK researchers (£750,000) and The Chinese Ministry of Science and Technology will invest up to 60 million Renminbi (RMB) to fund the project. Projects can last up to 3 years.

UK applicants must demonstrate that projects are primarily and directly relevant to the needs of people in low and middle income countries (LMICs), including China, as defined by the Organisation for Economic Co-operation and Development (OECD). There must be a clear economic and societal benefit to LMICs from their proposed project. The competition will open on 3 April 2018 (Innovation Funding Service)